Asset Details
Do you wish to reserve the book?
Calafate (Berberis buxifolia Lam.) Berry as a Source of Bioactive Compounds with Potential Health-Promoting Effects: A Critical Review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Calafate (Berberis buxifolia Lam.) Berry as a Source of Bioactive Compounds with Potential Health-Promoting Effects: A Critical Review
Do you wish to request the book?
Calafate (Berberis buxifolia Lam.) Berry as a Source of Bioactive Compounds with Potential Health-Promoting Effects: A Critical Review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Calafate (Berberis buxifolia Lam.) Berry as a Source of Bioactive Compounds with Potential Health-Promoting Effects: A Critical Review
2025
Overview
Calafate berry, an ancient perennial shrub of South America (Chile and Argentina), produces a high antioxidant capacity berry with a high polyphenol (1344.2–6553 mg GAE/100 g d.w.) and anthocyanin (26.5–80 mg C-3-G/100 g d.w.) content. The beneficial effects of calafate berries on human health are related to the anti-inflammatory, hypoglycemic, anticancer, and antioxidant properties that the berries possess, which have been confirmed through evidence to date, primarily from in vitro, ex vivo, and animal studies. Several investigations have shown a relationship between the consumption of calafate and a reduction in the risk of contracting cardiovascular diseases (CVD). This was evident in changes in plasma level biomarkers related to CVD, such as thrombomodulin (−24%), adiponectin (+68%), sE-selectin (−34%), sICAM-1 (−24%) and proMMP-9 (−31%), and changes in the production of OH radicals in plasma (−17%) after calafate intake. Calafate may have an antithrombotic role that supports cardiovascular health by lowering the Atherogenic and Cardiovascular Risk Indices. Various authors indicate delphinidin-3-glucoside (384–386 mg/100 g) as the primary bioactive compound responsible for the beneficial properties of Calafate. Although some studies report calafate’s health benefits, scientific evidence, especially in humans, remains limited. Meanwhile, Chile is working to domesticate and cultivate calafate, aiming to turn it from a wild native berry into a sustainable crop for use in the antioxidants and nutraceuticals industry. The lack of human clinical trials emphasizes the need for future research to validate calafate’s health benefits berry.
We currently cannot retrieve any items related to this title. Kindly check back at a later time.